Clinical Trial Update: Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the efficacy and safety of sarilumab for adults with early polymyalgia rheumatica; recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polymyalgia Rheumatica

Drugs mentioned

• Sarilumab (sarilumab)

Snippet

Sponsor: Sanofi | Conditions: Polymyalgia Rheumatica | Phase 4 | Status: NOT_YET_RECRUITING